Gaucher Disease Treatments
Find Gaucher Disease Treatments
Brand Name
Elelyso
Generic Name
Taliglucerase
View Brand Information FDA approval date: May 01, 2012
Classification: Hydrolytic Lysosomal Glucocerebroside-specific Enzyme
Form: Injection
What is Elelyso (Taliglucerase)?
ELELYSO is indicated for the treatment of patients 4 years of age and older with a confirmed diagnosis of Type 1 Gaucher disease. ELELYSO is a hydrolytic lysosomal glucocerebroside-specific enzyme indicated for the treatment of patients 4 years and older with a confirmed diagnosis of Type 1 Gaucher disease .
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Tired of the same old research?
Related Clinical Trials
There is no clinical trials being done for this treatment